Corvus Pharmaceuticals Earning Date (CRVS)

USA |NASDAQ |USD

CRVS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 23, 2022 Dec 2021 $-0.22 $-0.24 $-0.34
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 23, 2022 Dec 2021 $0.00 $0.00 $0.00

Corvus Pharmaceuticals's next earnings date is Wednesday, Mar 23, 2022 for the fiscal quarter ending Dec 2021.

CRVS Earnings Date & History Chart

CRVS Earnings & Revenue Forecast

CRVS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 2 $-0.23 $-0.31 $-0.15
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $-0.85 $-0.96 $-0.64

CRVS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Mar 2022 2 / 0 $-0.30 $-0.30 $-0.30
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 0 $-0.90 $-0.90 $-0.90

CRVS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Mar 2022 2 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $0.00 $0.00 $0.00

CRVS Earnings Date & Revenue History

CRVS Earnings History

|
Show More
Show More

CRVS Revenue History

|
Show More
Show More

Corvus Pharmaceuticals Next Earnings Date & Report

CRVS Next Earnings Date & Report Preview: Dec 2021 (FQ)

CRVS's next earnings date is Wednesday, Mar 23, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 3 analysts, the average EPS estimation for Corvus Pharmaceuticals's next quarterly earnings is $-0.22, with a low EPS estimation of $-0.27, and a high estimation of $-0.17.

Over the last 1 month, EPS estimates have seen 2 upward revisions and 0 downward. The EPS 1 month trend is $-0.22, the last 2 month trend is $-0.22, and the 3 month trend is $-0.22.

Based on 3 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Corvus Pharmaceuticals Previous Earnings Dates & Reports

CRVS Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Corvus Pharmaceuticals's previous earnings date was Nov 1, 2021 for its fiscal quarter ended Sep 30, 2021.

CRVS's earnings per share (EPS) was $-0.24, missing the consensus analysts forecast of $-0.24 by -1.05%.

The EPS was higher than the previous fiscal quarter (Jun 2021) by -14.29%, and higher than the same period a year before (Sep 2020) by -27.27%.

Revenues were $0.00.

The company reported a net income of $-10.67M.

Free cash flow for the quarter was $-8.43M , compared to $-12.65M last quarter and $-7.81M a year before.

CRVS ended the quarter with $3.88M in total debt, an increase of 117.77% compared to the previous quarter, and an increase of 53.13% compared to the same quarter a year before.

CRVS Previous Earnings Date & Report Recap: Dec 2020 (FY)

Corvus Pharmaceuticals's previous annual earnings date was Mar 25, 2021 for its fiscal year ended Dec 31, 2020.

CRVS's earnings per share (EPS) was $-1.47, missing the consensus analysts forecast of $-1.46 by 0.73% , and higher than the previous year's EPS (Dec 2019) by -7.50%.

Revenues were $0.00.

The company reported a net income of $-6.00M.

Corvus Pharmaceuticals reported a free cash flow of $-34.85M for its fiscal year, compared to $-37.35M a year ago.

The company ended the fiscal year with $2.31M in total debt, a decrease of -27.54% compared to the previous year.